The market for Global Human Insulin is expected to reach up to $40 billion by the end of the forecasted period and is expected to grow at a CAGR of 10-12%.
The major factors contributing to the market growth are; increase in prevalence of diabetic population, rise in geriatric population, rising awareness of diabetes and rising prevalence of obesity.
Human insulin is also known as synthetic insulin which is prepared in laboratory and has same characteristics like natural insulin. Human insulin was developed through the 1960s and 1970s and approved for pharmaceutical use in 1982. Before the invention of human insulin animal insulin, usually a purified form of porcine was used.
However, strict regulatory requirements for approval of insulin and high cost of analog are inhibiting the growth of the global human insulin market. Along with that, delayed onset of action, and various side effects of human insulin are also limiting the growth of this market across the globe.
Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/951
Major Key Players
- Biocon Ltd. (India),
- Tonghua Dongbao Pharmaceuticals Co., Ltd. (China),
- Adocia (France.),
- Merck & Co. (U.S.),
- Julphar (UAE),
- Bristol-Myers Squibb Company (U.S.),
- GlaxoSmithKline Plc (U.K.),
- Oramed Pharmaceuticals, Inc. (Israel),
- Novo Nordisk A/S (Denmark),
- Increasing prevalence of diabetic population, rising prevalence of obesity, and rise in geriatric population are major factors driving the growth of the human insulin market
- Strict regulatory requirements for approval of insulin and high cost of insulin analog inhibits the growth of the human insulin market
- Geographically, North America has the largest share in global human insulin market, while Asia-Pacific has emerged as the fastest growing region
- Based on the type, modern human insulin has the largest market share in the human insulin market
Test the market data and market information presented through more than 34 market data tables and 28 figures spread over 180 numbers of pages of the project report. Avail the in-depth TOC & market synopsis on “Global Human Insulin Market Research Report – Forecast 2011 To 2021”
Access Report Details @ https://www.marketresearchfuture.com/reports/human-insulin-market-951
Global Human Insulin market has been segmented on the basis of types which majorly includes modern human insulin, and traditional human insulin. The modern human insulin is further divided into; long acting human insulin, rapid acting human insulin, and premixed human insulin. Whereas, the traditional human insulin is again categorized into; short acting human insulin, and intermediate acting human insulin.
Table of Content
- Company Profile
9.1 Biocon Ltd
9.1.1 Company Overview
9.1.2 Product/Business Segment Overview
9.1.3 Financial Updates
9.1.4 Key Developments
9.2 Tonghua Dongbao Pharmaceuticals Co
9.2.1 Company Overview
9.2.2 Product/Business Segment Overview
9.2.3 Financial Updates
9.2.4 Key Developments
9.3 Adocia, Merck & Co
9.3.1 Company Overview
9.3.2 Product/Business Segment Overview
9.3.3 Financial Updates
9.3.4 Key Developments
9.4.1 Company Overview
9.4.2 Product/Business Segment Overview
9.4.3 Financial Updates
9.4.4 Key Developments
Browse Related Statistical Reports
The global micro-pump market by industry is expected to grow at a rate of 9.3% during the forecasted period. Pharmaceutical industry segment commands the largest market share of 54.6% of total market and is expected to reach at USD 2,998.9 million by 2027.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Name: Akash Anand
Organization: Market Research Future
Address: Market Research Future Office No. 524/528,
Phone: +1 646 845 9312